Put Options

7 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$1.19 - $1.74 $6,545 - $9,570
-5,500 Reduced 27.78%
14,300 $22,000
Q2 2024

Aug 15, 2024

SELL
$1.28 - $1.9 $12,544 - $18,620
-9,800 Reduced 33.11%
19,800 $25,000
Q1 2024

May 07, 2024

BUY
$1.35 - $2.27 $810 - $1,362
600 Added 2.07%
29,600 $47,000
Q4 2023

Feb 14, 2024

BUY
$1.27 - $2.06 $14,859 - $24,102
11,700 Added 67.63%
29,000 $51,000
Q3 2023

Nov 14, 2023

BUY
$1.8 - $3.61 $31,140 - $62,453
17,300 New
17,300 $36,000
Q4 2022

Feb 14, 2023

SELL
$1.6 - $2.37 $13,920 - $20,619
-8,700 Reduced 37.66%
14,400 $26,000
Q3 2022

Nov 14, 2022

SELL
$2.04 - $4.32 $3,876 - $8,208
-1,900 Reduced 7.6%
23,100 $49,000

Others Institutions Holding ICAD

About ICAD INC


  • Ticker ICAD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 25,333,900
  • Market Cap $42.6M
  • Description
  • iCAD, Inc. provides image analysis, workflow solutions, and radiation therapy for the treatment of cancer in the United States. It operates through two segments, Cancer Detection and Cancer Therapy. The company offers PowerLook platform, which hosts the AI algorithm solutions and manages the communications between imaging acquisition systems, an...
More about ICAD
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.